Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications
Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilisation. However, considerable variation in their use and prices. Objective: Assess the influence of multiple supply and demand-side ini...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
17 June 2014
|
| In: |
Frontiers in pharmacology
Year: 2014, Jahrgang: 5 |
| ISSN: | 1663-9812 |
| DOI: | 10.3389/fphar.2014.00106 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3389/fphar.2014.00106 Verlag, lizenzpflichtig, Volltext: https://www.frontiersin.org/articles/10.3389/fphar.2014.00106/full 
|
| Verfasserangaben: | Brian Godman, Bjorn Wettermark, Menno van Woerkom, Jessica Fraeyman, Samantha Alvarez-Madrazo, Christian Berg, Iain Bishop, Anna Bucsics, Stephen Campbell, Alexander E. Finlayson, Jurij Fürst, Kristina Garuoliene, Harald Herholz, Marija Kalaba, Ott Laius, Jutta Piessnegger, Catherine Sermet, Ulrich Schwabe, Vera V. Vlahović-Palčevski, Vanda Markovic-Pekovic, Luka Vončina, Kamila Malinowska, Corinne Zara and Lars L. Gustafsson |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 172552029X | ||
| 003 | DE-627 | ||
| 005 | 20230426183751.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 200724s2014 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fphar.2014.00106 |2 doi | |
| 035 | |a (DE-627)172552029X | ||
| 035 | |a (DE-599)KXP172552029X | ||
| 035 | |a (OCoLC)1341347887 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Godman, Brian |e VerfasserIn |0 (DE-588)1084653958 |0 (DE-627)848636600 |0 (DE-576)456594396 |4 aut | |
| 245 | 1 | 0 | |a Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures |b findings and future implications |c Brian Godman, Bjorn Wettermark, Menno van Woerkom, Jessica Fraeyman, Samantha Alvarez-Madrazo, Christian Berg, Iain Bishop, Anna Bucsics, Stephen Campbell, Alexander E. Finlayson, Jurij Fürst, Kristina Garuoliene, Harald Herholz, Marija Kalaba, Ott Laius, Jutta Piessnegger, Catherine Sermet, Ulrich Schwabe, Vera V. Vlahović-Palčevski, Vanda Markovic-Pekovic, Luka Vončina, Kamila Malinowska, Corinne Zara and Lars L. Gustafsson |
| 264 | 1 | |c 17 June 2014 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 24.07.2020 | ||
| 520 | |a Introduction: The appreciable growth in pharmaceutical expenditure has resulted in multiple initiatives across Europe to lower generic prices and enhance their utilisation. However, considerable variation in their use and prices. Objective: Assess the influence of multiple supply and demand-side initiatives across Europe for established medicines to enhance prescribing efficiency before a decision to prescribe a particular medicine. Subsequently utilise the findings to suggest potential future initiatives that countries could consider. Method: Analysis of different methodologies involving cross national and single country retrospective observational studies on reimbursed use and expenditure of PPIs, statins and renin-angiotensin inhibitor drugs among European countries. Results: Nature and intensity of the various initiatives appreciably influenced prescribing behaviour and expenditure, e.g. multiple measures resulted in reimbursed expenditure for PPIs in Scotland in 2010 56% below 2001 levels despite a 3 fold increase in utilisation and in the Netherlands, PPI expenditure fell by 58% in 2010 vs. 2000 despite a 3-fold increase in utilisation. A similarly picture was seen with prescribing restrictions, i.e. (i) more aggressive follow-up of prescribing restrictions for patented statins and ARBs resulted in a greater reduction in the utilisation of patented statins in Austria vs. Norway and lower utilisation of patented ARBs vs. generic ACEIs in Croatia than Austria. However, limited impact of restrictions on esomeprazole in Norway with the first prescription or recommendation in hospital where restrictions do not apply. Similar findings when generic losartan became available in Western Europe. Conclusions: Multiple demand-side measures are needed to influence prescribing patterns. When combined with supply-side measures, activities can realise appreciable savings. Health authorities cannot rely on a ‘spill over’ effect between classes to affect changes in prescribing | ||
| 650 | 4 | |a demand-side measures | |
| 650 | 4 | |a drug utilisation studies | |
| 650 | 4 | |a generics | |
| 650 | 4 | |a PPIs | |
| 650 | 4 | |a renin-angiotensin inhibitor drugs | |
| 650 | 4 | |a Statins | |
| 700 | 1 | |a Wettermark, Bjorn |e VerfasserIn |4 aut | |
| 700 | 1 | |a van Woerkom, Menno |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fraeyman, Jessica |e VerfasserIn |4 aut | |
| 700 | 1 | |a Alvarez-Madrazo, Samantha |e VerfasserIn |4 aut | |
| 700 | 1 | |a Berg, Christian |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bishop, Iain |e VerfasserIn |4 aut | |
| 700 | 1 | |a Bucsics, Anna |e VerfasserIn |4 aut | |
| 700 | 1 | |a Campbell, Stephen |e VerfasserIn |4 aut | |
| 700 | 1 | |a Finlayson, Alexander E. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fürst, Jurij |e VerfasserIn |4 aut | |
| 700 | 1 | |a Garuoliene, Kristina |e VerfasserIn |4 aut | |
| 700 | 1 | |a Herholz, Harald |e VerfasserIn |4 aut | |
| 700 | 1 | |a Kalaba, Marija |e VerfasserIn |4 aut | |
| 700 | 1 | |a Laius, Ott |e VerfasserIn |4 aut | |
| 700 | 1 | |a Piessnegger, Jutta |e VerfasserIn |4 aut | |
| 700 | 1 | |a Sermet, Catherine |e VerfasserIn |4 aut | |
| 700 | 1 | |a Schwabe, Ulrich |d 1935-2021 |e VerfasserIn |0 (DE-588)172366399 |0 (DE-627)697310019 |0 (DE-576)13323133X |4 aut | |
| 700 | 1 | |a Vlahović-Palčevski, Vera V. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Markovic-Pekovic, Vanda |e VerfasserIn |4 aut | |
| 700 | 1 | |a Vončina, Luka |e VerfasserIn |4 aut | |
| 700 | 1 | |a Malinowska, Kamila |e VerfasserIn |4 aut | |
| 700 | 1 | |a Zara, Corinne |e VerfasserIn |4 aut | |
| 700 | 1 | |a Gustafsson, Lars L. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Frontiers in pharmacology |d Lausanne : Frontiers Media, 2010 |g 5(2014) Artikel-Nummer 106, 9 Seiten |h Online-Ressource |w (DE-627)642889392 |w (DE-600)2587355-6 |w (DE-576)335527108 |x 1663-9812 |7 nnas |a Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures findings and future implications |
| 773 | 1 | 8 | |g volume:5 |g year:2014 |a Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures findings and future implications |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fphar.2014.00106 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fphar.2014.00106/full |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20200724 | ||
| 993 | |a Article | ||
| 994 | |a 2014 | ||
| 998 | |g 172366399 |a Schwabe, Ulrich |m 172366399:Schwabe, Ulrich |d 50000 |d 54600 |e 50000PS172366399 |e 54600PS172366399 |k 0/50000/ |k 1/50000/54600/ |p 18 | ||
| 999 | |a KXP-PPN172552029X |e 3729198890 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"recId":"172552029X","relHost":[{"origin":[{"dateIssuedDisp":"2010-","dateIssuedKey":"2010","publisher":"Frontiers Media","publisherPlace":"Lausanne"}],"id":{"issn":["1663-9812"],"eki":["642889392"],"zdb":["2587355-6"]},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Frontiers in pharmacology","title":"Frontiers in pharmacology"}],"pubHistory":["2010 -"],"part":{"year":"2014","volume":"5","text":"5(2014) Artikel-Nummer 106, 9 Seiten"},"note":["Gesehen am 08.09.20"],"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures findings and future implicationsFrontiers in pharmacology","recId":"642889392","language":["eng"]}],"language":["eng"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"note":["Gesehen am 24.07.2020"],"id":{"eki":["172552029X"],"doi":["10.3389/fphar.2014.00106"]},"title":[{"title_sort":"Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures","title":"Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures","subtitle":"findings and future implications"}],"origin":[{"dateIssuedDisp":"17 June 2014","dateIssuedKey":"2014"}],"name":{"displayForm":["Brian Godman, Bjorn Wettermark, Menno van Woerkom, Jessica Fraeyman, Samantha Alvarez-Madrazo, Christian Berg, Iain Bishop, Anna Bucsics, Stephen Campbell, Alexander E. Finlayson, Jurij Fürst, Kristina Garuoliene, Harald Herholz, Marija Kalaba, Ott Laius, Jutta Piessnegger, Catherine Sermet, Ulrich Schwabe, Vera V. Vlahović-Palčevski, Vanda Markovic-Pekovic, Luka Vončina, Kamila Malinowska, Corinne Zara and Lars L. Gustafsson"]},"person":[{"role":"aut","display":"Godman, Brian","roleDisplay":"VerfasserIn","given":"Brian","family":"Godman"},{"role":"aut","display":"Wettermark, Bjorn","roleDisplay":"VerfasserIn","given":"Bjorn","family":"Wettermark"},{"family":"van Woerkom","given":"Menno","roleDisplay":"VerfasserIn","display":"van Woerkom, Menno","role":"aut"},{"display":"Fraeyman, Jessica","roleDisplay":"VerfasserIn","role":"aut","family":"Fraeyman","given":"Jessica"},{"roleDisplay":"VerfasserIn","display":"Alvarez-Madrazo, Samantha","role":"aut","family":"Alvarez-Madrazo","given":"Samantha"},{"display":"Berg, Christian","roleDisplay":"VerfasserIn","role":"aut","family":"Berg","given":"Christian"},{"display":"Bishop, Iain","roleDisplay":"VerfasserIn","role":"aut","family":"Bishop","given":"Iain"},{"family":"Bucsics","given":"Anna","display":"Bucsics, Anna","roleDisplay":"VerfasserIn","role":"aut"},{"given":"Stephen","family":"Campbell","role":"aut","roleDisplay":"VerfasserIn","display":"Campbell, Stephen"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Finlayson, Alexander E.","given":"Alexander E.","family":"Finlayson"},{"family":"Fürst","given":"Jurij","roleDisplay":"VerfasserIn","display":"Fürst, Jurij","role":"aut"},{"given":"Kristina","family":"Garuoliene","role":"aut","display":"Garuoliene, Kristina","roleDisplay":"VerfasserIn"},{"given":"Harald","family":"Herholz","role":"aut","roleDisplay":"VerfasserIn","display":"Herholz, Harald"},{"family":"Kalaba","given":"Marija","display":"Kalaba, Marija","roleDisplay":"VerfasserIn","role":"aut"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Laius, Ott","given":"Ott","family":"Laius"},{"given":"Jutta","family":"Piessnegger","role":"aut","roleDisplay":"VerfasserIn","display":"Piessnegger, Jutta"},{"given":"Catherine","family":"Sermet","role":"aut","display":"Sermet, Catherine","roleDisplay":"VerfasserIn"},{"role":"aut","display":"Schwabe, Ulrich","roleDisplay":"VerfasserIn","given":"Ulrich","family":"Schwabe"},{"given":"Vera V.","family":"Vlahović-Palčevski","role":"aut","roleDisplay":"VerfasserIn","display":"Vlahović-Palčevski, Vera V."},{"role":"aut","display":"Markovic-Pekovic, Vanda","roleDisplay":"VerfasserIn","given":"Vanda","family":"Markovic-Pekovic"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Vončina, Luka","given":"Luka","family":"Vončina"},{"display":"Malinowska, Kamila","roleDisplay":"VerfasserIn","role":"aut","family":"Malinowska","given":"Kamila"},{"role":"aut","display":"Zara, Corinne","roleDisplay":"VerfasserIn","given":"Corinne","family":"Zara"},{"family":"Gustafsson","given":"Lars L.","display":"Gustafsson, Lars L.","roleDisplay":"VerfasserIn","role":"aut"}]} | ||
| SRT | |a GODMANBRIAMULTIPLEPO1720 | ||